BSH18_Chris Response to CAR T-cell treatment in CLL patients

Patients with advanced chronic lymphocytic leukemia (CLL) don't respond well to chimeric antigen receptor (CAR) T-cell therapy. In this interview, Chris Fegan, MB, MD, FRCP, FRCPath, from Cardiff Univ... Author: VJHemOnc Added: 07/24/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts